BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28263001)

  • 21. Associations between Bone Material Strength Index, Calcaneal Quantitative Ultrasound, and Bone Mineral Density in Men.
    Rufus-Membere P; Holloway-Kew KL; Diez-Perez A; Kotowicz MA; Pasco JA
    J Endocr Soc; 2021 Apr; 5(4):bvaa179. PubMed ID: 33728389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone material strength index as measured by impact microindentation is altered in patients with acromegaly.
    Malgo F; Hamdy NAT; Rabelink TJ; Kroon HM; Claessen KMJA; Pereira AM; Biermasz NR; Appelman-Dijkstra NM
    Eur J Endocrinol; 2017 Mar; 176(3):339-347. PubMed ID: 28077497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density.
    Baldini M; Casirati G; Ulivieri FM; Cassinerio E; Khouri Chalouhi K; Poggiali E; Borin L; Burghignoli V; Cesana BM; Cappellini MD
    Blood Cells Mol Dis; 2018 Feb; 68():148-152. PubMed ID: 28693786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women with previous stress fractures show reduced bone material strength.
    Duarte Sosa D; Fink Eriksen E
    Acta Orthop; 2016 Dec; 87(6):626-631. PubMed ID: 27321443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone density changes with enzyme therapy for Gaucher disease.
    Lebel E; Dweck A; Foldes AJ; Golowa Y; Itzchaki M; Zimran A; Elstein D
    J Bone Miner Metab; 2004; 22(6):597-601. PubMed ID: 15490271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reference Intervals for Bone Impact Microindentation in Healthy Adults: A Multi-Centre International Study.
    Rufus-Membere P; Holloway-Kew KL; Diez-Perez A; Appelman-Dijkstra NM; Bouxsein ML; Eriksen EF; Farr JN; Khosla S; Kotowicz MA; Nogues X; Rubin M; Pasco JA
    Calcif Tissue Int; 2023 Mar; 112(3):338-349. PubMed ID: 36729139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status.
    Giraldo P; Pérez-López J; Núñez R; de la Puebla RF; Luño E; Saura-Grau S; Bureo JC; Plaza S; de la Serna J
    Blood Cells Mol Dis; 2016 Jan; 56(1):23-30. PubMed ID: 26603719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact microindentation assesses subperiosteal bone material properties in humans.
    Rokidi S; Bravenboer N; Gamsjaeger S; Misof B; Blouin S; Chavassieux P; Klaushofer K; Paschalis E; Papapoulos S; Appelman-Dijkstra N
    Bone; 2020 Feb; 131():115110. PubMed ID: 31655220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are the High Hip Fracture Rates Among Norwegian Women Explained by Impaired Bone Material Properties?
    Duarte Sosa D; Vilaplana L; Güerri R; Nogués X; Wang-Fagerland M; Diez-Perez A; F Eriksen E
    J Bone Miner Res; 2015 Oct; 30(10):1784-9. PubMed ID: 25900016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
    Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
    Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mean Bone Material Strength Index Values for Women are Lower Than Those for Men: Data from a Single Geographical Location.
    Holloway-Kew KL; Rufus-Membere PG; Anderson KB; Harland JW; Diez-Perez A; Kotowicz MA; Pasco JA
    Calcif Tissue Int; 2023 Nov; 113(5):511-514. PubMed ID: 37666992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gaucher disease and its treatment options.
    Bennett LL; Mohan D
    Ann Pharmacother; 2013 Sep; 47(9):1182-93. PubMed ID: 24259734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTH and bone material strength in hypoparathyroidism as measured by impact microindentation.
    Starr JR; Tabacco G; Majeed R; Omeragic B; Bandeira L; Rubin MR
    Osteoporos Int; 2020 Feb; 31(2):327-333. PubMed ID: 31720712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
    Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
    Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction.
    Elstein D; Foldes AJ; Zahrieh D; Cohn GM; Djordjevic M; Brutaru C; Zimran A
    Blood Cells Mol Dis; 2011 Jun; 47(1):56-61. PubMed ID: 21536468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease.
    Reed MC; Bauernfreund Y; Cunningham N; Beaton B; Mehta AB; Hughes DA
    Gene; 2018 Dec; 678():196-206. PubMed ID: 30099023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological changes of lumbar vertebral bodies and intervertebral discs associated with decrease in bone mineral density of the spine: a cross-sectional study in elderly subjects.
    Kwok AW; Wang YX; Griffith JF; Deng M; Leung JC; Ahuja AT; Leung PC
    Spine (Phila Pa 1976); 2012 Nov; 37(23):E1415-21. PubMed ID: 22914705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of osteopenia/osteoporosis in adult scoliosis: does bone density affect surgical outcome?
    Yagi M; King AB; Boachie-Adjei O
    Spine (Phila Pa 1976); 2011 Sep; 36(20):1652-7. PubMed ID: 21304426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat.
    Kamath RS; Lukina E; Watman N; Dragosky M; Pastores GM; Arreguin EA; Rosenbaum H; Zimran A; Aguzzi R; Puga AC; Norfleet AM; Peterschmitt MJ; Rosenthal DI
    Skeletal Radiol; 2014 Oct; 43(10):1353-60. PubMed ID: 24816856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.